Drug safety test: how liver health affects medication processing
NCT ID NCT07025551
Summary
This study aimed to understand how an experimental drug called MK-8527 is processed by the body in people with mild or moderate liver impairment. Researchers compared the drug's behavior in 18 participants—some with liver problems and some healthy. The goal was to gather safety information to guide future dosing for patients with liver conditions.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Arizona Clinical Trials ( Site 0001)
Chandler, Arizona, 85225, United States
Conditions
Explore the condition pages connected to this study.